DNA Microarray Chips Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (cDNA Microarrays, Oligo DNA Microarrays, BAC Microarrays, SNP Microarrays); Application (Gene Expression, Cancer Diagnosis and Treatment, Genotyping, Genomics, Drug Discovery, Others); End-User (Academic and Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Others)
Report Code: TIPRE00008472 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET OVERVIEW
A DNA chip, also called a DNA microarray, is an analytical tool consisting of many DNA fragments closely placed on a resin or glass substrate for detection of changes in expression of genes in samples. DNA microarrays are used in various research areas because they allow comprehensive analysis of several hundred to several hundred thousand genes with a small amount of sample and in a comparatively short time. Many DNA microarrays, including 3D-Gene, are used in research aiming toward their practical use in clinical or industrial practice.
MARKET SCOPE
The "Global DNA Microarray Chips Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the DNA microarray chips market with detailed market segmentation by type, application, end-user and geography. The report provides key statistics on the market status of the leading DNA microarray chips market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints:
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The DNA microarray chips market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the DNA microarray chips market in these regions.
IMPACT OF COVID-19 ON DNA MICROARRAY CHIPS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. DNA microarray chips market is moderately affected due to COVID-19.
The report covers key developments in the DNA microarray chips market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from DNA microarray chips market are anticipated to lucrative growth opportunities in the future with the rising demand for DNA microarray chips in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the DNA microarray chips market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
A DNA chip, also called a DNA microarray, is an analytical tool consisting of many DNA fragments closely placed on a resin or glass substrate for detection of changes in expression of genes in samples. DNA microarrays are used in various research areas because they allow comprehensive analysis of several hundred to several hundred thousand genes with a small amount of sample and in a comparatively short time. Many DNA microarrays, including 3D-Gene, are used in research aiming toward their practical use in clinical or industrial practice.
MARKET SCOPE
The "Global DNA Microarray Chips Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the DNA microarray chips market with detailed market segmentation by type, application, end-user and geography. The report provides key statistics on the market status of the leading DNA microarray chips market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- On the basis of type, the market is segmented into cDNA Microarrays, Oligo DNA Microarrays, BAC Microarrays, and SNP Microarrays.
- Based on application, the market is bifurcated into gene expression, cancer diagnosis and treatment, genotyping, genomics, drug discovery, and others.
- Based on end-user, the market is bifurcated into academic and government research institutes, hospitals and diagnostics centers, biotechnology and pharmaceutical companies, and others.
MARKET DYNAMICS
Drivers:
- Surge in Demand for Personalized Cancer Treatment.
- Growth in Genomics Research and Development
- Increasing Demand for Early Cancer Diagnosis & Cancer Detection.
- Large Scale DNA Chip Initiatives
- Increasing Government Funding for Research
Restraints:
- Alternate Technologies.
- Lack of professionals with Adequate Technical and Clinical Skills
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The DNA microarray chips market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the DNA microarray chips market in these regions.
IMPACT OF COVID-19 ON DNA MICROARRAY CHIPS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. DNA microarray chips market is moderately affected due to COVID-19.
The report covers key developments in the DNA microarray chips market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from DNA microarray chips market are anticipated to lucrative growth opportunities in the future with the rising demand for DNA microarray chips in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the DNA microarray chips market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Affymetrix Inc.
- Agilent Technologies Inc.
- Illumina, Inc.
- Perkin Elmer, Inc.
- Eurofins Genomics LLC
- Thermo Fisher Scientific, Inc.
- Macrogen Inc.
- Nipro Greiner Bio-One GmbH
- CapitalBio Corporation
- Roche NimbleGen Inc.
The List of Companies
1. Affymetrix Inc.
2. Agilent Technologies Inc.
3. Illumina, Inc.
4. Perkin Elmer, Inc.
5. Eurofins Genomics LLC
6. Thermo Fisher Scientific, Inc.
7. Macrogen Inc.
8. Nipro Greiner Bio-One GmbH
9. CapitalBio Corporation
10. Roche NimbleGen Inc.
1. Affymetrix Inc.
2. Agilent Technologies Inc.
3. Illumina, Inc.
4. Perkin Elmer, Inc.
5. Eurofins Genomics LLC
6. Thermo Fisher Scientific, Inc.
7. Macrogen Inc.
8. Nipro Greiner Bio-One GmbH
9. CapitalBio Corporation
10. Roche NimbleGen Inc.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount